Mon, Dec 22, 2014, 4:54 AM EST - U.S. Markets open in 4 hrs 36 mins

Recent

% | $
Quotes you view appear here for quick access.

Momenta Pharmaceuticals Inc. Message Board

oilpooldeeps 9 posts  |  Last Activity: Nov 12, 2014 7:44 PM Member since: May 7, 2011
SortNewest  |  Oldest  |  Highest Rated Expand all messages
  • oilpooldeeps by oilpooldeeps Nov 12, 2014 7:44 PM Flag

    I don't care if it goes to 10.00 tomorrow. It was 1% of my portfolio and i can't be bothered with it. Too much of a mess, and I very much suspect the dividend is not properly funded at this point.

    I moved the funds to add to a clean energy etf that I own - but if I was going to take a different REIT I think I would take W P Carey. However - WPC yields about 5.7 % , and historically it averaged about 6.5% so when rates even begin to rise, it will probably revert closer to the mean and I guess I'll wait for that type of a scenario. . I'd like to get 6% for yield if nothing else

    But enough silliness with ARCP. shareholders are responsible when they chase high yield companies who have obvious operating or solvency or structural issues - but shareholders are not responsible for this kind of junk. I hope the FBI et al really deals some hard smacks to a few people here.

  • wait 3 years for the dividend to get me my $$$ back. Who could want more from an investment??? And no, I couldn't be bothered to average down. Its only about 1.5% of my portfolio so phukkit.

  • You'd think that with all the reinvestment in business, Amazon would present as an unassailable fortress. But they look more to be vulnerable and under increasing attack. The online market is going from a centralized one company deal to a fragmented market that will end up with too many players. Wal Mart, Alibaba, Staples, Best Buy, you name it - everyone is getting in on it - any large company with decent resources. . And much more to come. Only the Fed Ex and Ups will benefit in the end.
    Amazon also looks wildly unfocused. Google has the same issue - investing in all kinds of experimental tech in the race to be the biggest player in future-world. But Google has done a much better job, and has the distinction of massive resources that keep increasing. It's cash horde is insane. Amazon is being run into the dirt, getting poorer. Maybe Alibaba will buy them.

  • I sold this at 100.00 some time ago after a long run up. Then watched it climb to 108.00 . It was nice to get the chance to get back in at 98.00. Some use came of the little panic anyway. Surprising now looking at the chart how sharp that little selloff was. hard to catch the bottom for much though, it was gone in a flash.

  • Reply to

    Decent earnings, but ....

    by oilpooldeeps Oct 14, 2014 12:52 PM
    oilpooldeeps oilpooldeeps Oct 14, 2014 7:15 PM Flag

    That may be but Johnson and Johnson will always be judged by its consumer division - it is not a pharma growth stock. Period. Everyone knows the surge in pharma is not sustainable. And the consumer division was flat to slightly negative, and devices was down with margin pressure on the horizon. That is why it is down. Throw in the earnings hit coming from olysio next year, and there wasn't really all that much to get excited about. It was a workmanlike report from a core holding. So some sell-off in a difficult market, it isn't surprising.

  • oilpooldeeps by oilpooldeeps Oct 14, 2014 12:52 PM Flag

    A lot of it was pharma gains. There are a horde of new drugs in the works all across the board, and there are basically upcoming threats to any drug out there. Olysio is pretty much guaranteed to take a big hit from the GILD combo therapy, among others.

    Its the softness in the more stable businesses that has the market yawning a bit.

  • oilpooldeeps by oilpooldeeps Oct 13, 2014 6:26 PM Flag

    I wonder what will come of the rreceptos drug. I think its a good 3 years at least from hitting the market if not more. It is more like Gilenya in design but perhaps more effective and a bit safer? Gilenya is more effective than tecfidera but not as safe. I was expecting receptos to be bought by someone at some point.

  • oilpooldeeps oilpooldeeps Oct 6, 2014 8:02 PM Flag

    Good luck with that thought. Have fun.

  • If they either go through creditor protection, or just flat out go under , it makes no difference whether they have 1.76/share of assets or 2.32 or whatever. As a common shareholder, you will get none of it. Zero. So I don't know why some people are expecting the share price to trace whatever they think the liquidated value actually is. Its not gonna. Don't confuse the concerns of shareholders with the concerns of creditors. Add in the massive pile of cash that will end up in the pockets of lawyers when you look at the assets anyway. .

MNTA
11.72-0.25(-2.09%)Dec 19 4:00 PMEST

Trending Tickers

i
Trending Tickers features significant U.S. stocks showing the most dramatic increase in user interest in Yahoo Finance in the previous hour over historic norms. The list is limited to those equities which trade at least 100,000 shares on an average day and have a market cap of more than $300 million.